Application of plant extract composition in preparation of preparation for promoting expression of skin antibacterial peptide and cosmetic

Through the plant extraction compositions of Coptis chinensis, Magnolia officinalis and Kawagiko, the subcritical and low-temperature extraction technology, the problems of inadequate expression of skin antibacterial peptides and the stability of extracts in the prior art are solved, and the effective promotion of antibacterial peptides in cosmetics and Improved safety.

CN118902931AActive Publication Date: 2024-11-08SHANGHAI AZ SCIENCE & TECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410941140.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-08
Estimated Expiration
2044-07-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively promote the expression of skin antibacterial peptides, especially hBD-2, hBD-3 and LL-37, and traditional extraction methods have problems with irritating odor and stability.

Method used

Using plant extraction compositions of Coptis chinensis, Magnolia officinalis and Chuanmus, through subcritical extraction and low-temperature extraction technology, combined with desorption of polyol aqueous solution, cosmetics that promote the expression of antimicrobial peptides in the skin are prepared, optimized the mass ratio and process conditions of the extracted raw materials, and improved the extraction. purity and efficacy of the substance.

Benefits of technology

It significantly promotes the expression of skin antimicrobial peptides, reduces the toxicity to HaCaT cells, improves the stability and odor of the extract, and is safe and effective for use as a cosmetic.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118902931A_ABST
    Figure CN118902931A_ABST
Patent Text Reader

Abstract

The invention relates to application of a plant extract composition in preparation of a preparation for promoting expression of skin antibacterial peptides and cosmetics. The plant extract composition comprises coptis chinensis and mangnolia officinalis extract which is obtained by extracting a mixture of coptis chinensis and mangnolia officinalis as an extraction raw material; the common vladimiria root extract is obtained by extracting common vladimiria root serving as an extraction raw material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of cosmetic technology, and in particular to an application of a plant extract composition in the preparation of a preparation for promoting the expression of skin antimicrobial peptides and cosmetics. Background Art

[0002] Antimicrobial peptides are a class of peptides with multiple activities produced by the body's biological defense system. It can be used to resist the invasion of foreign pathogens and is an important component of biological autoimmunity. Initially, people only found that this active peptide can exert a wide range of inhibitory effects on bacteria. Later, it was discovered that some antimicrobial peptides can also show killing effects on fungi, protozoa, tumor cells and viruses. Antimicrobial peptides have a wide antibacterial spectrum and non-unique targets, so it is difficult for microorganisms to develop resistance to antimicrobial peptides. Therefore, antimicrobial peptides have the potential to become a substitute for traditional antibiotics. In addition to resisting foreign pathogens, the immunoregulatory function of antimicrobial peptides has received increasing attention. Antimicrobial peptides have a small molecular weight and weak immunogenicity, and are important mediators of natural immunity. Antimicrobial peptides can inhibit pro-inflammatory cytokines, avoid endotoxemia caused by bacterial products, and inhibit the activity of certain enzymes that have inhibitory effects on wound healing, preventing wound deterioration, etc.

[0003] Defensins are one of the most studied antimicrobial peptides. Based on their structural characteristics, they are roughly divided into α-defensins and β-defensins. β-defensins are polypeptide substances that can be expressed in mucosal epithelia such as skin, lungs, organs, kidneys, reproductive organs, etc. So far, six human β-defensins have been isolated and confirmed: human β-defensin-1 (hBD-1), human β-defensin-2 (hBD-2), human β-defensin-3 (hBD-3), human β-defensin-4 (hBD-4), human β-defensin-5 (hBD-5) and human β-defensin-6 (hBD-6).

[0004] In addition, LL-37 antimicrobial peptide has an α-helical structure and has a wide range of antimicrobial activity and inflammatory regulation functions in the body. Studies have shown that when the skin is physiologically damaged or infected, it secretes defensins and LL-37 as antimicrobial peptides to induce antimicrobial activity and systemic immune response, especially inducing the differentiation and proliferation of epidermal glial cells, thereby repairing the wound.

[0005] At low concentrations, hBD-2 can attract monocytes, macrophages and neutrophils to migrate to the mucosa and skin invaded by pathogenic microorganisms through the chemokine receptor CCR2, thereby enhancing the local defense function. hBD-3 plays an important role in maintaining the homeostasis of the skin barrier. hBD-3 can enhance the barrier function of the skin by directly increasing the expression of Claudin in tight junction proteins or enhancing the expression of atypical Rac1 in the regulation of skin barrier function, such as activated protein kinase C, glycogen synthase kinase-3 and phosphatidylinositol 3-kinase. β-defensins have obvious antimicrobial effects and can effectively resist the invasion of microorganisms such as bacteria, fungi and viruses. They are the first natural line of defense for humans. hBD-3 alleviates IL-4 and IL-13-mediated tight junction (TJ) barrier damage by activating keratinocyte autophagy (involving aryl hydrocarbon receptor (AhR) signal transduction). LL-37 is a regulator of keratinocyte apoptosis and can regulate cytokines and chemokines to enhance their antifungal effects. LL-37 can act as an inflammatory inducer and also as an anti-inflammatory mediator to exert different immunomodulatory effects. LL-37 can promote the production of the anti-inflammatory factor IL-IRA and inhibit the inflammatory response induced by IL-32 by inducing the phosphorylation of MKP-1. Exogenous LL-37 can induce a proinflammatory response and induce neutrophils to clear Pseudomonas aeruginosa from the lungs without direct bactericidal activity. LL-37 has the effect of chemotaxis of different immune cells: LL-37 can chemotaxis neutrophils, eosinophils, monocytes and T cells. LL-37 can induce macrophages to differentiate into M1 cells with proinflammatory characteristics; dendritic cells can significantly upregulate the phagocytic ability of phagocytes, promote Th1 response and release related inflammatory factors after being induced by LL-37 in vitro.

[0006] References:

[0007] (1) Zhou Hai, Wei Li, Ma Ping. Research progress of human β-defensin-2[J]. Chongqing Medicine, 2014, 43(11): 1386-1387.

[0008] (2) Zhao Xinfei, Tian Yan, He Congfen, et al. Research progress on endogenous antimicrobial peptides human β-defensin and LL-37 in the skin[J]. Journal of Clinical Dermatology, 2023, 52(03): 190-192. DOI: 10.16761 / j.cnki.1000-4963.2023.03.020.

[0009] (3) Zhao Yadong, Qu Zhiguo, Li Lizhong. Research progress of human β-defensins[J]. Inner Mongolia Journal of Traditional Chinese Medicine, 2012, 31(05): 101-102. DOI: 10.16040 / j.cnki.cn15-1101.2012.05.087.

[0010] (4)Peng G, Tsukamoto S, Ikutama R, Nguyen HLT, Umehara Y, Trujillo-PaezJV, Yue H, Takahashi M, Ogawa T, Kishi R, Tominaga M, Takamori K, Kitaura J, Kageyama S, Komatsu M, Okumura K, Ogawa H, Ikeda S, Niyonsaba F.Humanβ-defensin-3attenuatesatopic dermatitis-like inflammation through autophagy activation and the arylhydrocarbon receptor signaling pathway.J Clin Invest.2022Sep 1;132(17):e156501.doi:10.1172 / JCI156501.PMID:35834333;PMCID:PMC9435650. Summary of the invention

[0011] In view of the problems existing in the prior art, the embodiments of the present application provide an application of a plant extract composition in the preparation of a preparation for promoting the expression of antimicrobial peptides in the skin and a cosmetic.

[0012] In a first aspect, the present application provides an application of a plant extract composition in the preparation of a preparation for promoting the expression of skin antimicrobial peptides, the plant extract composition comprising:

[0013] Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material;

[0014] Sichuan costusroot extract: extracted from Sichuan costusroot as the raw material.

[0015] In some embodiments, the promoting the expression of skin antimicrobial peptides is: promoting the expression of hBD-2, hBD-3 and LL-37 genes at the mRNA level.

[0016] In some embodiments, the mass ratio of the extraction raw materials Rhizoma Coptidis, Magnolia Officinalis and Aucklandia Sinensis is 1:(0.8-1.2):(0.8-1.2).

[0017] In some embodiments, the mass ratio of the extraction raw materials Rhizoma Coptidis, Magnolia Bark and Aucklandia Sinensis is 1:1:1.

[0018] In some embodiments, the plant extract composition is prepared by the following steps:

[0019] Mixing coptis root and magnolia bark and performing subcritical extraction to obtain a first extract;

[0020] Cooling the first extract to crystallize and then drying to obtain a first extract product;

[0021] Mixing Sichuan costusroot and organic base for extraction to obtain a second extract;

[0022] The second extract is subjected to resin adsorption and then desorbed with a polyol aqueous solution to obtain a desorbed solution;

[0023] The desorption liquid is mixed with the first extraction product to obtain the plant extract composition.

[0024] In some embodiments, the step of mixing Rhizoma Coptidis and Cortex Magnoliae Bark for subcritical extraction to obtain a first extract comprises:

[0025] Mix and grind Coptis chinensis and Magnolia officinalis, put them into a subcritical extraction tank, add deionized water for high temperature and high pressure extraction, and filter to obtain a first extract; wherein,

[0026] In some embodiments, the extraction temperature of the high temperature and high pressure extraction is 105° C. to 120° C., and the extraction pressure is 1.3 to 1.5 standard atmospheric pressures.

[0027] In some embodiments, the step of extracting the mixed leaves of Aucklandia lappa and an organic base to obtain a second extract comprises:

[0028] Take Sichuan costusroot and grind it, add organic base and deionized water to carry out low-temperature extraction, and filter after extraction to obtain the second extract; wherein,

[0029] In some embodiments, the extraction temperature of the low-temperature extraction is 40°C to 55°C.

[0030] In some embodiments, the organic base comprises one or more of betaine, L-carnitine, and stachydrine.

[0031] In some embodiments, the mass ratio of the Sichuan costusroot to the organic base is 1:(0.08-0.12).

[0032] In some embodiments, the resin used for the resin adsorption includes one or both of polyamide resin and cage resin.

[0033] In some embodiments, the polyol includes one or more of glycerol, 1,3-propylene glycol, 1,3-butylene glycol, 1,2-propylene glycol, dipropylene glycol, and methylpropylene glycol.

[0034] In some embodiments, the mass concentration of the polyol aqueous solution is 55% to 65%.

[0035] In some embodiments, the mass ratio of the Sichuan costusroot to the polyol aqueous solution is 1:(11.76-16.66).

[0036] In a second aspect, the present application provides a preparation for promoting the expression of antimicrobial peptides in the skin, which comprises a plant extract composition, wherein the plant extract composition comprises:

[0037] Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material;

[0038] Sichuan costus root extract: extracted from Sichuan costus root as the raw material;

[0039] in,

[0040] The method of administering the preparation for promoting skin antimicrobial peptide expression is in vitro and / or in vivo.

[0041] In a third aspect, the embodiments of the present application provide a cosmetic comprising a preparation for promoting the expression of skin antimicrobial peptides according to the embodiments of the second aspect of the present application. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] In order to more clearly illustrate the technical solution of the embodiments of the present application, the following is a brief introduction to the drawings required for use in the embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without any creative work.

[0043] Figure 1 These are the results of the HaCaT cell toxicity experiment in the examples of this application.

[0044] Figure 2-1 This is the experimental result of promoting the expression of hBD-2 at the mRNA level in the examples of this application.

[0045] Figure 2-2 This is the experimental result of promoting the expression of hBD-3 at the mRNA level in the examples of this application.

[0046] Figure 3 The results of the expression experiment of the antimicrobial peptide LL-37 at the mRNA level in the examples of this application are shown.

[0047] Figure 4 This is the result of the clinical acne skin redness removal test in the examples of this application.

[0048] Figure 5 This is the result of the clinical acne volume change test in the examples of this application.

[0049] Figure 6 These are the results of a clinical skin oil content change test in the examples of this application.

[0050] Figure 7 These are the results of a clinical skin transepidermal water loss change test in the examples of this application.

[0051] Figure 8 This is a VISA collection diagram for clinical acne removal in the embodiment of this application (the darker the color, the higher the relative height of the acne). DETAILED DESCRIPTION

[0052] The features and exemplary embodiments of various aspects of the present application will be described in detail below. In the detailed description below, many specific details are proposed to provide a comprehensive understanding of the present application. However, it is obvious to those skilled in the art that the present application can be implemented without the need for some of these specific details. The following description of the embodiments is only to provide a better understanding of the present application by illustrating the examples of the present application. In the following description, at least part of the known structures and technologies are not shown to avoid unnecessary ambiguity in the present application; and, for clarity, the size of some structures may be exaggerated. In addition, the features, structures or characteristics described below may be combined in one or more embodiments in any suitable manner.

[0053] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish an entity or operation from another entity or operation, and do not necessarily require or imply that there is any such actual relationship or order between these entities or operations. In the description of the present application, it should be noted that, unless otherwise specified, the meaning of "multiple" is more than two. Moreover, the term "include", "comprise" or any other variant thereof is intended to cover non-exclusive inclusion, so that the process, method, article or equipment including a series of elements not only include those elements, but also include other elements not clearly listed, or also include elements inherent to such process, method, article or equipment. In the absence of more restrictions, the elements limited by the sentence "include..." do not exclude the existence of other identical elements in the process, method, article or equipment including the elements.

[0054] The embodiment of the first aspect of the present application provides an application of a plant extract composition in preparing a preparation for promoting the expression of skin antimicrobial peptides, wherein the plant extract composition comprises:

[0055] Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material;

[0056] Sichuan costusroot extract: extracted from Sichuan costusroot as the raw material.

[0057] In some embodiments, promoting the expression of skin antimicrobial peptides is: promoting the expression of hBD-2, hBD-3 and LL-37 genes at the mRNA level.

[0058] The inventors have found that the plant extract composition obtained by compounding Coptis chinensis, Magnolia officinalis and Aucklandia lappa can effectively promote the expression of antimicrobial peptides in the skin, especially the expression of human β-defensin-2 (hBD-2), human β-defensin-3 (hBD-3) and LL-37 antimicrobial peptides. In addition, the plant extract composition provided in the embodiment of the present application is prepared and matched with Chinese medicine components, which has low irritation and few side effects, and can reduce the incidence of infection and complications caused by long-term use of hormones. At the same time, traditional Chinese medicine has a good regulatory effect on the immune function of the human body and can repair the skin barrier.

[0059] In some embodiments, the mass ratio of the extraction raw materials Rhizoma Coptidis, Magnolia Bark and Aucklandia Sinensis is 1:(0.8-1.2):(0.8-1.2).

[0060] In some embodiments, the mass ratio of the extraction raw materials Coptis chinensis, Magnolia officinalis and Aucklandia lappa is 1:1:1.

[0061] By limiting the ratio of each extraction raw material within the above range, the obtained extract can have a better compatibility effect, further improving the efficacy of the plant extract composition, so that it has a better effect of promoting the expression of skin antimicrobial peptides.

[0062] In some implementations, the plant extract composition is prepared by the following steps:

[0063] S100, taking coptis root and magnolia bark and mixing them for subcritical extraction to obtain a first extract;

[0064] S200, cooling and crystallizing the first extract and then drying it to obtain a first extraction product;

[0065] S300, extracting the atractylodes rose and an organic base to obtain a second extract;

[0066] S400, subjecting the second extract to resin adsorption and then desorption with a polyol aqueous solution to obtain a desorption solution;

[0067] S500, mixing the desorption liquid with the first extraction product to obtain the plant extract composition.

[0068] In some embodiments, the mass ratio of Coptis chinensis, Magnolia officinalis and Aucklandia lappa is 1:(0.8-1.2):(0.8-1.2); in some embodiments, the mass ratio of the extraction raw materials Coptis chinensis, Magnolia officinalis and Aucklandia lappa is 1:1:1.

[0069] By limiting the mass ratio of Coptis chinensis, Magnolia officinalis and Aucklandia lappa within the above range, the mixed extraction effect of Coptis chinensis and Magnolia officinalis is better, the purity and extraction rate of the extract can be further improved, and the components can have a better synergistic effect when combined according to the above ratio, which is beneficial to improving the effect of promoting the expression of antimicrobial peptides in the skin.

[0070] In some embodiments, step S100 includes:

[0071] The coptis root and magnolia bark are mixed and crushed, put into a subcritical extraction tank, added with deionized water for high temperature and high pressure extraction, and filtered to obtain a first extract.

[0072] Coptis chinensis contains more berberine, coptisine, methyl coptisine, palmitoyl tetrandrine and other alkaloid components, and Magnolia officinalis contains more active ingredients, magnolol. When Coptis chinensis and Magnolia officinalis are crushed and mixed for extraction, the alkaloids in Coptis chinensis can serve as ion donors, and the magnolol in Magnolia officinalis serves as ion receptors. The two can form supramolecular compound crystals by cocrystalization, thereby improving the extraction efficiency and product purity of Coptis chinensis and Magnolia officinalis, and obtaining a high-purity crystalline extract. The obtained crystals are filtered and dried to obtain the first extraction product.

[0073] In some embodiments, the extraction temperature of the high temperature and high pressure extraction may be 105° C. to 120° C., and the extraction pressure may be 1.3 to 1.5 standard atmospheric pressures. In the present application, the standard atmospheric pressure is 101.325 KPa.

[0074] Limiting the extraction temperature and extraction pressure of Coptis chinensis and Magnolia officinalis to the above ranges can improve the extraction efficiency and effectiveness, and increase the concentration of active ingredients in the extract.

[0075] In some embodiments, step S300 includes: grinding the costusroot, adding an organic base and deionized water for low-temperature extraction, and filtering after extraction to obtain a second extract.

[0076] Sichuan costus root contains a large number of flavonoid active ingredients. When Sichuan costus root is crushed and mixed with an organic base for extraction, the flavonoids in Sichuan costus root can act as ion receptors and the organic base can act as ion donors. The two can form supramolecular compound crystals in a cocrystal, thereby extracting the active ingredients in Sichuan costus root, thereby improving the efficiency of Sichuan costus root extraction and the purity of the product. In the subsequent resin adsorption process, since the adsorption resin does not adsorb the organic base, the organic base in the second extract can be separated from the Sichuan costus root extract.

[0077] In some embodiments, the extraction temperature of the low-temperature extraction may be 40° C. to 55° C. Within this extraction temperature range, the purity and extraction efficiency of the extracted product may be improved.

[0078] In some embodiments, the organic base includes one or more combinations of betaine, L-carnitine, and stachydrine.

[0079] In some embodiments, the mass ratio of Sichuan costusroot to the organic base can be 1: (0.08-0.12).

[0080] The above-mentioned organic base can form supramolecular compound crystals with the flavonoid active ingredients in Sichuan costusroot, which can further improve the extraction efficiency and the purity of the extracted product.

[0081] The second extract can be adsorbed by resin to remove impurities such as organic bases, and the resin used for adsorption can be one or more of polyamide resin and snake cage resin. The above-mentioned adsorption resin can effectively adsorb the flavonoid active ingredients in the second extract, and hardly adsorbs or rarely adsorbs organic bases, so it can be used for adsorption and separation of active ingredients and organic bases in the second extract.

[0082] The active ingredients adsorbed by the adsorption resin are eluted with a polyol, which may include one or more of glycerol, 1,3-propylene glycol, 1,3-butylene glycol, 1,2-propylene glycol, dipropylene glycol, and methyl propylene glycol.

[0083] Polyols can act as solvents in the plant extract composition to evenly disperse the components and improve the contact of the extract components in the plant extract composition on the skin surface.

[0084] In some embodiments, the mass concentration of the polyol aqueous solution may be 55% to 65%.

[0085] An embodiment of the second aspect of the present application provides a preparation for promoting the expression of antimicrobial peptides in the skin, comprising a plant extract composition, wherein the plant extract composition comprises:

[0086] Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material;

[0087] Sichuan costus root extract: extracted from Sichuan costus root as the raw material;

[0088] in,

[0089] The method of administering the preparation for promoting the expression of antimicrobial peptides in the skin is in vitro and / or in vivo.

[0090] The embodiment of the third aspect of the present application provides a cosmetic, including the preparation for promoting the expression of skin antimicrobial peptides according to the embodiment of the second aspect of the present application.

[0091] Example

[0092] The present invention is described below with reference to specific examples. It should be noted that the examples described below are exemplary and are only used to explain the present application, and should not be construed as limiting the present application. If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in this area or the product specifications are used. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be obtained commercially.

[0093] Example 1

[0094] A plant extract composition is prepared by the following method:

[0095] S100, take 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0096] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of 60% 1,3-propylene glycol back water solution for 1 h, the elution temperature was 55°C, the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0097] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0098] Example 2

[0099] A plant extract composition is prepared by the following method:

[0100] S100, take 6kg of Coptis chinensis and 6kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract for 2h at 125℃ and 1.5 times standard atmospheric pressure, cool the extract to below 95℃, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0101] S200, 6 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.65 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0102] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0103] Example 3

[0104] A plant extract composition is prepared by the following method:

[0105] S100, take 8.5kg of Coptis chinensis and 8.5kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0106] S200, 8.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.85 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-butanediol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0107] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0108] Example 4

[0109] A plant extract composition is prepared by the following method:

[0110] S100, take 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let crystallize for 24h, and collect the crystals by suction;

[0111] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of betaine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0112] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0113] Example 5

[0114] A plant extract composition is prepared by the following method:

[0115] S100, take 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let crystallize for 24h, and collect the crystals by suction;

[0116] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 120 kg of 65% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0117] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0118] Example 6

[0119] A plant extract composition is prepared by the following method:

[0120] S100, take 7.5kg of Coptis chinensis and 9.0kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let crystallize for 24h, and collect the crystals by suction;

[0121] S200, 9.0 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 90 kg of a 55% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0122] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a plant extract composition.

[0123] Comparative Example 1

[0124] S100, grind 7.5 kg of Coptis chinensis and Magnolia officinalis respectively, pass through a 60-mesh sieve and put into a subcritical extraction tank, add 100 kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2 h, cool the extract to below 95°C, filter with a 0.45 μm nylon membrane, let crystallize for 24 h, and collect the crystals by suction;

[0125] S200, adding the crystals collected in step S100 into 100 kg of 60% 1,3-propylene glycol aqueous solution, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a comparative composition 1.

[0126] Comparative Example 2

[0127] S100, grind 7.5 kg of Coptis chinensis, pass through a 60-mesh sieve and put into a subcritical extraction tank, add 1700 kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2 hours, cool the extract to below 95°C, filter with a 0.45 μm nylon membrane, let crystallize for 24 hours, and collect the crystals by suction;

[0128] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 90 ° C for 2 h, the extract was filtered, the filtrate was collected and added to the polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg and 760% 1,3-butanediol for 1 h, and the elution temperature was 55 ° C. The eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0129] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 2.

[0130] Comparative Example 3

[0131] S100, crush 7.5 kg of Magnolia officinalis, pass through a 60-mesh sieve, add 100 kg of deionized water and extract at high temperature for 2 h, filter through a 0.45 μm nylon membrane, let the filtrate stand for 24 h for crystallization, and collect the crystals by suction;

[0132] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 90°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0133] S300, adding the crystals collected in step S100 to the filtrate of S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 3.

[0134] Comparative Example 4

[0135] S100, grind 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, pass through a 60-mesh sieve, add 100kg of deionized water and extract at 100℃ for 2h, filter with a 5μm polypropylene membrane; let the filtrate stand for crystallization for 24h, and collect the crystals by suction;

[0136] S200, adding the crystals collected in step S100 into 100 kg of 60% 1,3-propylene glycol aqueous solution, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 4.

[0137] Comparative Example 5

[0138] S100, grind 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, pass through a 60-mesh sieve, add 100kg of deionized water and extract at 100℃ for 2h, filter with a 5μm polypropylene membrane; let the filtrate stand for crystallization for 24h, and collect the crystals by suction;

[0139] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.75 kg of L-carnitine were added, and the mixture was extracted at 90°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0140] S300, adding the crystals collected in step S100 to the filtrate of S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 5.

[0141] Comparative Example 6

[0142] S100, grind 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, pass through a 60-mesh sieve and put into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let crystallize for 24h, and collect the crystals by suction;

[0143] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water was added, and the mixture was extracted at 90°C for 2 h. The extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C. The eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0144] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 6.

[0145] Comparative Example 7

[0146] S100, grind 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, add 100kg of deionized water and extract at 100℃ for 2h, filter through 0.45μm nylon membrane, let the filtrate stand for 24h for crystallization, and collect the crystals by suction;

[0147] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water was added, and the mixture was extracted at 90°C for 2 h. The extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C. The eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0148] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 7.

[0149] Comparative Example 8

[0150] A composition is prepared by the following method:

[0151] S100, 5.5 kg of Coptis chinensis and 5.5 kg of Magnolia officinalis were mixed and crushed, passed through a 60-mesh sieve and put into a subcritical extraction tank, 100 kg of deionized water was added, and the mixture was extracted at 125°C and 1.5 times the standard atmospheric pressure for 2 h. The extract was cooled to below 95°C and filtered with a 0.45 μm nylon membrane. The filtrate was allowed to crystallize for 24 h, and the crystals were collected by suction filtration;

[0152] S200, 5.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.55 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0153] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 8.

[0154] Comparative Example 9

[0155] A composition is prepared by the following method:

[0156] S100, take 9.0kg of Coptis chinensis and 9.0kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0157] S200, 9.0 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 1.08 kg of L-carnitine were added, and the mixture was extracted at 50°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100 kg of a 60% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0158] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain comparative composition 9.

[0159] Comparative Example 10

[0160] A composition is prepared by the following method:

[0161] S100, take 7.5kg of Coptis chinensis and 10kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract for 2h at 125℃ and 1.5 times standard atmospheric pressure, cool the extract to below 95℃, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0162] S200, 5kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100kg of deionized water and 0.4kg of L-carnitine were added, and the mixture was extracted at 50°C for 2h, the extract was filtered, the filtrate was collected and added to polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 100kg of 60% 1,3-propylene glycol aqueous solution for 1h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0163] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a comparative composition 10.

[0164] Comparative Example 11

[0165] A composition is prepared by the following method:

[0166] S100, take 7.5kg of Coptis chinensis and 7.5kg of Magnolia officinalis, mix and grind them, pass through a 60-mesh sieve and put them into a subcritical extraction tank, add 100kg of deionized water, extract at 125°C and 1.5 times the standard atmospheric pressure for 2h, cool the extract to below 95°C, filter with a 0.45μm nylon membrane, let the filtrate stand for crystallization for 24h, and collect the crystals by suction filtration;

[0167] S200, 7.5 kg of Sichuan costus root was crushed, passed through a 60-mesh sieve, 100 kg of deionized water and 0.5 kg of L-carnitine were added, and the mixture was extracted at 60°C for 2 h, the extract was filtered, the filtrate was collected and added to a polyamide resin for static adsorption, and the resin was collected by filtering with a 500-mesh filter bag. The resin was eluted with 130 kg of a 70% 1,3-propylene glycol aqueous solution for 1 h at an elution temperature of 55°C, and the eluate was filtered with a 500-mesh filter bag, and the filtrate was collected;

[0168] S300, adding the crystals collected in step S100 to the filtrate collected in step S200, stirring and dissolving at 60°C for 1 hour to form a transparent solution, and filtering with a 0.45 μm nylon membrane to obtain a comparative composition 11.

[0169] Test Section

[0170] 1. Appearance and stability test

[0171] The appearance of the compositions prepared in each example and comparative example was observed, and their stability after being placed in different environments for 3 months was recorded, as shown in Table 1.

[0172] Table 1

[0173]

[0174] According to the test results in Table 1, the color of the composition obtained by the traditional water extraction method or when the amount of the extracted raw materials is too much is generally dark yellow, and the composition obtained when the content of Sichuan costus root extract is high has a pungent odor, and the odor is strong, while the composition of the mixed extract of coptis root and magnolia bark and Sichuan costus root extract of the present application has no pungent odor, which is very important for the plant extract composition used as a cosmetic raw material. In addition, the addition of Sichuan costus root extract can improve the stability of the mixed extract of coptis root and magnolia bark, and reduce the discoloration and precipitation of the extract under high temperature or light conditions. And the composition obtained by subcritical extraction technology has the advantages of lighter odor and better stability compared with the composition obtained by traditional water extraction technology.

[0175] 2. Cell safety

[0176] Test method: HaCaT cells are human immortalized epidermal cell lines. The cytotoxicity of HaCaT cells can be used as a reference for skin safety. Normal cells have vigorous metabolism. The succinate dehydrogenase in their mitochondria can reduce tetrazolium salts to colored crystalline substances that are deposited around the cells. This change can be read by an OD (optical density) value using an enzyme reader. By comparing it with the OD value of the blank control group, the relative growth of the cells can be determined (the OD value is proportional to the cell survival rate). After treating the sample with an aqueous solution of a 0.5% concentration of a plant extract composition, the survival rate of HaCaT cells was determined using CCK-8. Cell survival rates above 75% were considered "non-toxic". The test results refer to Figure 1 .

[0177] Combination Figure 1 It can be seen from the test results that the plant extract compositions in Examples 1 to 6 are not cytotoxic to HaCaT cells, the compositions in Comparative Examples 5, 6, 8 to 11 are not cytotoxic to HaCaT cells, the compositions in Comparative Examples 1 to 4 are toxic to HaCaT cells, and the composition in Comparative Example 7 is weakly toxic to HaCaT cells. The above experimental results show that the combined extracts of the three raw materials of Coptis chinensis, Magnolia officinalis and Aucklandia lappa provided in the present application can significantly reduce the toxicity to HaCaT cells.

[0178] 3. Experiments on promoting the expression of defensins hBD-2 and hBD-3 at the mRNA level

[0179] 3.1 Extraction of total RNA from cells

[0180] (1) After 80%-90% confluent adherent cells in good growth condition, discard the culture medium and add total RNA extraction reagent Trizol at a rate of 3 mL / 10 cm diameter culture dish adherent cells. Pipette repeatedly until the liquid is completely transparent and leave at room temperature for 5 min.

[0181] (2) Add chloroform at a rate of 200 μL chloroform / 1 ml Trizol, invert the EP tube for 50 seconds, and leave at room temperature for 3 minutes.

[0182] (3) Centrifugation at 4°C, 12,000 rpm, for 15 min.

[0183] (4) Transfer the upper aqueous phase to another EP tube, add an equal volume of isopropanol and mix well, and leave at room temperature for 10 min.

[0184] (5) Centrifuge at 4°C, 12,000 rpm, for 10 min. Carefully pour off the liquid and allow the RNA to settle to the bottom of the tube.

[0185] (6) Wash the RNA precipitate with 1 ml of 75% ethanol (DEPC water, prepared freshly) and gently shake the centrifuge tube to suspend the precipitate.

[0186] (7) Centrifuge at 4°C, 8000 rpm, for 5 min. After discarding the ethanol, place the EP tube upside down on absorbent paper and dry the RNA precipitate at room temperature for about 10 min.

[0187] (8) Dissolve the RNA sample in 30 μL H2O (adjustable according to the amount of RNA), TE buffer or 0.5% SDS (sodium dodecyl sulfate) and store at -20°C (preferably -80°C). Note: H2O, TE or 0.5% SDS must be treated with DEPC and autoclaved.

[0188] 3.2 RNA concentration determination and reverse transcription

[0189] (1) Instrument: Micro-volume UV spectrophotometer

[0190] (2) RNA concentration unit: ng / μL; after measurement, the RNA template was diluted to 500 ng / μL;

[0191] (3) RT-PCR reverse transcription system is as follows (reagent company: TAKARA):

[0192] Element Volume (μL) 5x Prime Script Buffer(for Real Time) 4 Prime Script RT Enzyme Mix I 1 Random 6-mers 2 Total RNA (500ng / uL) 2 <![CDATA[RNase Free dH2O]]> 11

[0193] The program for reverse transcription of cDNA was: 37°C, 15 min; 85°C, 5S; 4°C cycle; Total: approx 15 min;

[0194] qRCR steps:

[0195] The primers were centrifuged at 12000 rpm for 5 min; water was added to dissolve the primers according to the recommended dosage and the concentration was 100 μM;

[0196] Take a new EP tube, take 5 μL of forward primer, 5 μL of reverse primer, add 40 μL of deionized water, mix well to get a primer concentration of 10 μM;

[0197] The concentration of reverse transcribed cDNA was determined and the cDNA was diluted to 200 ng / μL with deionized water.

[0198] The reverse transcription system is as follows:

[0199]

[0200]

[0201] The total volume of fluorescence quantitative PCR was 10 μL / tube;

[0202] Program: pre-denaturation 95°, 5 min, cycle number 1; denaturation 95°, 10 sec; annealing / extension 60°, 30 sec, cycle number 40; melting curve stage, cycle number 1.

[0203]

[0204] The experimental data are shown in Figure 2-1 , Figure 2-2 .

[0205] Combination Figure 2-1 , 2-2It can be seen from the test results that the plant extract compositions in Example 1, Comparative Example 7 and Comparative Example 2 at appropriate concentrations can promote the expression of hBD-2 and hBD-3 at the mRNA level. At the same concentration of 0.125%, the expression effects of Comparative Example 7 and Comparative Example 2 at the mRNA level of hBD-2 and hBD-3 were not obvious, and the expression promotion effect of Example 1 was significant. At the same concentration of 0.25%, Comparative Example 7, Comparative Example 2 and Example 1 can all significantly promote the expression of hBD-2 and hBD-3 at the mRNA level. From the data results, the expression effect of Example 1 at the mRNA level of hBD-2 and hBD-3 at the mRNA level of 0.125% and 0.25% concentrations is significantly better than that of Comparative Example 7 and Comparative Example 2 at the same concentration, and the expression effect of Comparative Example 7 at the mRNA level of hBD-2 and hBD-3 is slightly better than that of Comparative Example 2, that is, when the plant extract composition contains only Coptis chinensis and Aucklandia lappa, its expression effect of hBD-2 and hBD-3 at the mRNA level is weaker than that of the composition containing Coptis chinensis, Aucklandia lappa and Magnolia officinalis. The combination of coptis chinensis, magnolia bark and costus root extracted by supercritical technology and supramolecular technology has a significantly better effect on promoting the expression of hBD-2 and hBD-3 at the mRNA level than the traditional water-extracted combination of coptis chinensis, magnolia bark and costus root.

[0206] 4. Expression experiment of antimicrobial peptide LL-37 at mRNA level

[0207] 4.1 Extraction of total RNA from cells

[0208] (1) After 80-90% confluent adherent cells in good growth condition, discard the culture medium and add Trizol at a rate of 3 mL / 10 cm diameter culture dish adherent cells. Pipette repeatedly until the liquid is completely transparent and leave at room temperature for 5 min.

[0209] (2) Add chloroform at a rate of 200 μL chloroform / 1 ml Trizol, invert the EP tube for 50 seconds, and leave at room temperature for 3 minutes.

[0210] (3) Centrifugation at 4°C, 12,000 rpm, for 15 min.

[0211] (4) Transfer the upper aqueous phase to another EP tube, add an equal volume of isopropanol and mix well (about 200 μL-300 μL), and leave at room temperature for 10 min.

[0212] (5) Centrifuge at 4°C, 12,000 rpm, for 10 min. Carefully pour off the liquid and allow the RNA to settle to the bottom of the tube.

[0213] (6) Wash the RNA precipitate with 1 ml of 75% ethanol (DEPC water, prepared freshly) and gently shake the centrifuge tube to suspend the precipitate.

[0214] (7) Centrifuge at 4°C, 8,000 rpm, for 5 min. After discarding the ethanol, place the EP tube upside down on absorbent paper to dry the RNA precipitate at room temperature for about 10 min.

[0215] (8) Dissolve the RNA sample in 30 μL H2O (adjustable according to the amount of RNA), TE buffer or 0.5% SDS and store at -20°C (preferably -80°C). Note: H2O, TE or 0.5% SDS must be treated with DEPC and autoclaved.

[0216] 4.2 RNA concentration determination and reverse transcription

[0217] (1) Instrument: Micro-volume UV spectrophotometer

[0218] (2) RNA concentration unit: ng / μL; after measurement, the RNA template was diluted to 500 ng / μL;

[0219] (3) RT-PCR reverse transcription system is as follows (reagent company: TAKARA):

[0220] Element Volume (μL) 5x Prime Script Buffer(for Real Time) 4 Prime Script RT Enzyme Mix I 1 Random 6-mers 2 Total RNA (500ng / uL) 2 RNase Free dH2O 11

[0221] Reverse transcription cDNA program: 37°C, 15 min; 85°C, 5S; 4°C cycle; Total: approx 15 min;

[0222] qRCR steps:

[0223] The primers were centrifuged at 12000 rpm for 5 min; water was added to dissolve the primers according to the recommended dosage and the concentration was 100 μM;

[0224] Take a new EP tube, take 5 μL of forward primer, 5 μL of reverse primer, add 40 μL of deionized water, mix well to get a primer concentration of 10 μM;

[0225] The concentration of reverse transcribed cDNA was determined and the cDNA was diluted to 200 ng / μL with deionized water.

[0226] The reverse transcription system is as follows:

[0227] Element Volume (μL) HieffqPCR SYBR Green Master Mix(Low Rox PLus)(2X) 5 (F+R) Primer 1 Template cDNA (200ng / μL) 2 Sterile ultrapure water 2

[0228] The total volume of fluorescence quantitative PCR was 10 μL / tube.

[0229] Program: pre-denaturation at 95° for 5 min, cycle number 1; denaturation at 95° for 10 sec, annealing / extension at 60° for 30 sec, cycle number 40, melting curve stage, cycle number 1.

[0230]

[0231] The experimental data are shown in Figure 3 .

[0232] Combination Figure 3 It can be seen from the test results that the comparative example 2 with a concentration of 0.125% and 0.25% has no effect of promoting the expression of LL-37 at the mRNA level, while the comparative example 7 and Example 1 with the same concentration have the effect of promoting the expression of LL-37 at the mRNA level, wherein the comparative example 7 with a concentration of 0.25% and the Example 1 with a concentration of 0.125% and 0.25% have a significant effect of promoting the expression, and the expression promoting effect of Example 1 at a concentration of 0.125% is equivalent to the expression promoting effect of the comparative example 7 with a concentration of 0.25%. That is, the expression promoting effect of the composition containing only coptis chinensis and costus root at the mRNA level of LL-37 is weaker, while the expression promoting effect of the composition containing coptis chinensis, costus root and magnolia bark is stronger. The expression promoting effect of the coptis chinensis, costus root and magnolia bark obtained by traditional water extraction at the mRNA level of LL-37 is weaker than that of the coptis chinensis, costus root and magnolia bark obtained by subcritical technology and supramolecular extraction technology at the same concentration.

[0233] 5. Clinical acne removal effect

[0234] 1) Subject selection

[0235] 1.1 The inclusion criteria for the subjects are as follows:

[0236] Healthy male or female aged between 18 and 40 years old;

[0237] People with acne on their face;

[0238] The facial skin has no spots, moles, birthmarks or other phenomena that may affect the test;

[0239] The subjects do not have severe chronic wasting diseases (such as asthma, diabetes, etc.);

[0240] Those who have no allergic diseases, no history of allergies to cosmetics and other external preparations (products);

[0241] Comply with the trial requirements, voluntarily participate in the trial and sign the written informed consent;

[0242] Those who have not participated in other clinical trials in the past month;

[0243] No acne removal products have been used and no acne removal treatments (such as medications, injections, lasers, and other plastic surgeries) have been received in the past month.

[0244] 1.2 Subject exclusion criteria are as follows:

[0245] Women who are planning to become pregnant, are pregnant, breastfeeding, or within six months after giving birth;

[0246] Those with severe systemic diseases, immunodeficiency or autoimmune diseases;

[0247] Those who have used antihistamines in the past week or immunosuppressants in the past month;

[0248] Those who have used any anti-inflammatory drugs in the tested area in the past two months;

[0249] The tested site has participated in other clinical trials in the past three months;

[0250] People with pustules, nodules, and cystic acne on the face;

[0251] People who are receiving dermatological treatment;

[0252] Other patients deemed unsuitable for trial participation by clinical assessment.

[0253] 1.3 Other notes for the subjects:

[0254] During the test, the test parts should use the test products provided by the test agency, and no other products with the same number of classes or that may affect the test results should be used;

[0255] During the test, it is forbidden to take any preparations that may affect or potentially affect the test results (such as anti-inflammatory drugs, injections, etc.). If it is necessary to take any preparations, the test institution should be informed in advance.

[0256] During the test, the subjects maintained a regular lifestyle and paid attention to monitoring their diet:

[0257] It is prohibited to perform any cosmetic procedures or treatments that may affect the test results, such as laser spot removal and skin removal, during the test period.

[0258] 1.4 Subject Exit Criteria:

[0259] During the test, the subject experiences adverse reactions, is lost for no reason, or violates the test protocol (such as using other

[0260] In the case of influential cosmetics or drugs or other special reasons, after evaluation and confirmation by a dermatologist, if the subject is no longer suitable to continue the test, the subject will be asked to withdraw.

[0261] 2) Test site

[0262] Acne-prone areas on face.

[0263] 3) Inspection equipment

[0264] Instrument type and model:

[0265] Transepidermal water loss test probe Tewameter TM300 Courage-Khazaka, Germany;

[0266] Skin detector VISIA 7Canfield, USA;

[0267] 3D image acquisition system Antera 3DMiravex, Ireland;

[0268] Skin oil test probe Sebumeter SM815Courage-Khazaka, Germany;

[0269] 4) Inspection environment

[0270] Temperature 21℃±1℃;

[0271] Humidity 50% ± 10% RH;

[0272] 5) Inspection process

[0273] 5.1 Subject Screening

[0274] Recruit subjects as required and have them sign informed consent forms; ask subjects relevant questions based on the inclusion and exclusion criteria and record them together with the test screening results.

[0275] 5.2 Preparation before testing

[0276] On the day of the visit, no products can be applied to the test area. The subjects use a facial cleansing product without any efficacy provided by the laboratory to cleanse their faces. They sit in a constant temperature and humidity chamber for 30 minutes. They cannot drink hot water or eat hot food during this period. The test area cannot be exposed to water or touched.

[0277] 5.3 Initial value test

[0278] All subjects were tested using a before-and-after control design. After sitting quietly in a constant temperature and humidity room for 30 minutes, they were tested using relevant instruments. A unique code was compiled and recorded, which was recorded as the initial value "D O ”.

[0279] 5.4 Follow-up test

[0280] All subjects returned for a follow-up visit on the 1st, 3rd and 7th day. No products were allowed to be applied to the test areas on the day of the visit. Subjects cleansed their faces with a facial cleansing product that did not have any efficacy and was provided by the laboratory. After sitting in a constant temperature and humidity chamber for 30 minutes, they were tested with a facial image acquisition device and a skin color tester. A unique code was compiled and recorded as the test values ​​"D1", "D3" and "D7".

[0281] 5.5 Adverse reaction management

[0282] If the subject experiences adverse skin reactions during the use of the test sample, he / she should immediately stop using it and take appropriate medical protection measures, and record the adverse reaction event;

[0283] 5.6 Data Analysis

[0284] The measured values ​​of each test area are statistically analyzed, including quantity, mean, standard deviation, etc. The difference between the baseline value DO and D1, D3, and D7 of each test area is calculated.

[0285] The smear sample is a gel, and the composition is as shown in Table 2:

[0286] Table 2

[0287]

[0288] The results of the redness removal a value test refer to Figure 4 , acne volume test results refer to Figure 5 , skin oil content results refer to Figure 6 , the results of transepidermal water loss refer to Figure 7 , acne removal VISA chart reference Figure 8 .

[0289] from Figure 4 From the results of the a value change rate, both the control group and the sample group can remove the redness of the skin around acne, which is consistent with the repair and regulation function of human skin itself. From the results of the change rate, the redness removal effect of Examples 1 to 6 is significantly better than that of the comparative example and the control group. The examples can reduce the redness of the skin around acne by more than 13% on the 3rd day, and the redness of the skin around acne by more than 25% on the 7th day. The comparative example can reduce the redness of the skin around acne by 6% to 12% on the 3rd day, and the redness of the skin around acne by 11% to 23% on the 7th day.

[0290] from Figure 5 From the results of the acne volume change rate, both the control group and the sample group can remove acne, which is consistent with the repair and regulation function of human skin. From the results of the change rate, the acne removal effect of Examples 1 to 6 is significantly better than that of the comparative example and the control group. The examples can reduce the volume of acne by 30% to 45% on the third day, and by 45% to 55% on the seventh day. The comparative example can reduce the volume of acne by 4% to 25% on the third day, and by 8% to 40% on the seventh day.

[0291] from Figure 6 From the results of the change rate of skin oil content, the acne removal effects of Examples 1 to 6 are significantly better than those of the comparative example and the control group. The examples can reduce the skin oil content by 16% to 19% on the first day, the examples can reduce the skin oil content by 25% to 30% on the third day, and the skin oil content can be reduced by 37% to 40% on the seventh day. The comparative example can reduce the skin oil content by 4% to 14% on the first day, the examples can reduce the skin oil content by 14% to 23% on the third day, and the skin oil content can be reduced by 13% to 32% on the seventh day.

[0292] from Figure 7 From the results of the change rate of transepidermal water loss of the skin, both the control and sample groups can reduce the transepidermal water loss of the skin over time, which is consistent with the repair and regulation function of human skin itself. From the results of the change rate, the acne removal effect of Examples 1 to 6 is significantly better than that of the comparative example and the control group. The embodiment can reduce the transepidermal water loss of the acne surrounding muscle by 5% to 8% on the first day, and the embodiment can reduce the transepidermal water loss of the acne surrounding muscle by more than 22% to 23% on the third day, and can reduce the transepidermal water loss of the acne surrounding muscle by more than 29% to 34% on the seventh day. The comparative example can reduce the transepidermal water loss of the acne surrounding muscle by 1% to 5% on the first day, and can reduce the transepidermal water loss of the acne surrounding muscle by 9% to 21% on the third day, and can reduce the transepidermal water loss of the acne surrounding muscle by 15% to 28% on the seventh day.

[0293] from Figure 8 From the results of acne changes collected by VISA face, the volume of acne slowly decreases with the change of time, which is consistent with the repair and regulation function of human skin itself. After the gel of comparative example 10 is applied, it can be seen that the volume of acne is slightly reduced on the 7th day, and the acne protrusion (acne height) is slightly reduced, but the VISA image can still see that the color at the center of the acne is still darker, indicating that the acne is still in a raised state. After the gel of the sample group (Example 1) is applied, it can be seen that the volume of acne is significantly reduced on the 3rd day, and the acne protrusion (acne height) is significantly reduced. The VISA image on the 7th day shows that the center of the acne has no dark color at all, that is, the acne protrusion has disappeared. The above VISA images show that the acne removal effect of Example 1 is better than that of comparative example 10.

[0294] Although the present application has been described with reference to preferred embodiments, various modifications may be made thereto and parts thereof may be replaced with equivalents without departing from the scope of the present application. In particular, the various technical features mentioned in the various embodiments may be combined in any manner as long as there are no structural conflicts. The present application is not limited to the specific embodiments disclosed herein, but includes all technical solutions falling within the scope of the claims.

Claims

1. Use of a plant extract composition in the preparation of a preparation for promoting the expression of skin antimicrobial peptides, characterized in that: The plant extract composition comprises: Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material; Sichuan costusroot extract: extracted from Sichuan costusroot as the raw material.

2. The use according to claim 1, characterized in that: The method of promoting the expression of skin antimicrobial peptides is: promoting the expression of hBD-2, hBD-3 and LL-37 genes at the mRNA level.

3. The use according to claim 1, characterized in that: The mass ratio of the extraction raw materials, Coptis chinensis, Magnolia officinalis and Aucklandia lappa, is 1:(0.8-1.2):(0.8-1.2); optionally, the mass ratio of the extraction raw materials, Coptis chinensis, Magnolia officinalis and Aucklandia lappa is 1:1:

1.

4. The use according to claim 1, characterized in that: The plant extract composition is prepared by the following steps: Mixing coptis root and magnolia bark and performing subcritical extraction to obtain a first extract; Cooling the first extract to crystallize and then drying to obtain a first extract product; Mixing Sichuan costusroot and organic base for extraction to obtain a second extract; The second extract is subjected to resin adsorption and then desorbed with a polyol aqueous solution to obtain a desorbed solution; The desorption liquid is mixed with the first extraction product to obtain the plant extract composition.

5. The use according to claim 4, characterized in that: The step of mixing coptis root and magnolia bark for subcritical extraction to obtain a first extract comprises: Mix and grind Coptis chinensis and Magnolia officinalis, put them into a subcritical extraction tank, add deionized water for high temperature and high pressure extraction, and filter to obtain a first extract; wherein, Optionally, the extraction temperature of the high temperature and high pressure extraction is 105° C. to 120° C., and the extraction pressure is 1.3 to 1.5 standard atmospheric pressures.

6. The use according to claim 4, characterized in that: The step of extracting the mixed Sichuan costusroot and organic base to obtain the second extract comprises: Take Sichuan costusroot and grind it, add organic base and deionized water to carry out low-temperature extraction, and filter after extraction to obtain the second extract; wherein, Optionally, the extraction temperature of the low-temperature extraction is 40°C to 55°C.

7. The use according to claim 6, characterized in that: The organic base includes one or more of betaine, L-carnitine and stachydrine; and / or The mass ratio of the Sichuan costusroot to the organic base is 1:(0.08-0.12).

8. The use according to claim 4, characterized in that: The resin used for the resin adsorption includes one or both of polyamide resin and snake cage resin; and / or The polyol comprises one or more of glycerol, 1,3-propylene glycol, 1,3-butylene glycol, 1,2-propylene glycol, dipropylene glycol and methyl propylene glycol; and / or The mass concentration of the polyol aqueous solution is 55% to 65%; and / or The mass ratio of the Sichuan costusroot to the polyol aqueous solution is 1:(11.76-16.66).

9. A preparation for promoting the expression of antimicrobial peptides in the skin, characterized in that: The invention comprises a plant extract composition, wherein the plant extract composition comprises: Coptis chinensis and Magnolia officinalis extract: extracted from a mixture of Coptis chinensis and Magnolia officinalis as the raw material; Sichuan costus root extract: extracted from Sichuan costus root as the raw material; in, The method of administering the preparation for promoting skin antimicrobial peptide expression is in vitro and / or in vivo.

10. A cosmetic, characterized in that: A preparation for promoting the expression of antimicrobial peptides in the skin as claimed in claim 9.

Citation Information

Patent Citations

  • Pharmaceutical composition for treating acne

    CN116672380A